Cochlear implantation improves hearing in Meniere's disease

May 2, 2014
Cochlear implantation improves hearing in Ménière's disease

(HealthDay)—For patients with Ménière's disease (MD), cochlear implantation (CI) is associated with significant improvement in hearing performance, according to a study published online May 1 in JAMA Otolaryngology-Head & Neck Surgery.

Tim A. Fife, M.D., from the Wake Forest University School of Medicine in Winston-Salem, N.C., and colleagues conducted a retrospective review involving 10 patients who met the diagnostic criteria for definite MD and underwent 11 CIs from 2000 to 2012 (mean age at first implantation, 64 years). Patients answered questions regarding their current hearing ability, perception of symptoms, and functional status related to their MD before and after CI.

The researchers found that the mean sentence testing scores in quiet improved significantly, from 22.8 percent before CI to 77.0 percent after CI at the most recent follow-up (P < 0.001). The mean MD Functional Level Scale vestibular scores were similar pre- and post-CI (3.9 and 3.4, respectively; P = 0.52).

"Patients with MD who undergo CI are capable of achieving substantial receptive communication improvement comparable to the gains experienced by without MD," the authors write. "Implantation seems to neither adversely alter the natural history of vestibular function nor notable exacerbate auditory symptoms."

Explore further: Six-minute walk test could help guide heart failure treatment

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Interarm BP difference may up cardiac risk in diabetes

April 3, 2014

(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published online on March ...

Melanoma risk up in IBD independent of biologic therapy

January 31, 2014

(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Gastroenterology ...

Recommended for you

Zika in fetal brain tissue responds to a popular antibiotic

November 30, 2016

Working in the lab, UC San Francisco researchers have identified fetal brain tissue cells that are targeted by the Zika virus and determined that azithromycin, a common antibiotic regarded as safe for use during pregnancy, ...

Zika and glaucoma linked for first time in new study

November 30, 2016

A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus during gestation.

Flu forecasts successful on neighborhood level

November 30, 2016

Scientists at Columbia University's Mailman School of Public Health developed a computer model to predict the onset, duration, and magnitude of influenza outbreaks for New York City boroughs and neighborhoods. They found ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.